As Shift Bioscience raises $16 million in seed funding, delve into the field of cellular reprogramming to tackle age-related ...

Epilepsy, one of the most widespread neurological diseases in the world, characterized by recurrent seizures, affects approximately 50 million people globally. In Europe, up to six million people are ...

Booster Therapeutics, a Berlin-based biotech startup, has emerged from stealth with a $15 million seed financing led by Apollo Health Ventures and Novo Holdings. The company is developing a novel ...

JAK inhibitors have gained particular attention in the inflammation and immunology (I&I) space, an area that has brought in a wave of investment in recent times. Pharma giants such as Pfizer and ...